If you are a Class Member, you can tell the Court that you do not agree with the Settlement or some part of it. To object, you must send the Court a written statement that you object to the Settlement in Ford et al v. Takeda Pharmaceuticals U.S.A., Inc. et al., No. 21-cv-10090 (D. Mass.). Be sure to include your name, address, telephone number, signature, and a full explanation of why you object to the Settlement. Your written objection must be received by the Court no later than February 21, 2023. The Court’s address is United States District Court for the District of Massachusetts, John Joseph Moakley U.S. Courthouse, 1 Courthouse Way, Suite 2300, Courtroom 18, Boston, MA 02210. Your written objection also must be mailed to the lawyers listed below, no later than February 21, 2023. Please note that the Court’s Order Granting Preliminary Approval of this Settlement provides that any party to the litigation may, but is not required to, serve discovery requests, including requests for documents and notice of deposition not to exceed two hours in length, on any objector. Any responses to discovery, or any depositions, must be completed within ten days of the request being served to the objector.
Class Counsel
SCHLICHTER, BOGARD & DENTON
Attn: Takeda Pharmaceuticals 401(k) Settlement
100 S. Fourth St., Suite 1200
St. Louis, MO 63102
Defendants’ Counsel
MORGAN, LEWIS & BOCKIUS LLP
Attn: Abbey M. Glenn
1111 Pennsylvania Ave NW
Washington, DC 20004